Cite

    Moskovich, D., Alfandari, A., Finkelshtein, Y., Weisz, A., Katzav, A., Kidron, D., Edelstein, E., Veroslavski, D., Perets, R., Arbib, N., Kadan, Y., Fishman, A., Lerer, B., Ellis, M., & Ashur-Fabian, O. (2023). corrigendum to "DIO3, the thyroid hormone inactivating enzyme, promotes tumorigenesis and metabolic reprogramming in high grade serous ovarian cancer" [Canc. Lett. 501 224–233]. Cancer letters, 563, . http://access.bl.uk/ark:/81055/vdc_100185075382.0x00003c